Influence of interleukin-4 and platelet-activating factor on the Fc epsilon RII/CD23 expression on human monocytes

N Paul-Eugène1, B Dugas, S Picquot

  • 1Institut Henri Beaufour, Les Ulis, France.

Journal of Lipid Mediators
|March 1, 1990
PubMed

Insights

Platelet-activating factor (PAF) increases the expression of the IgE receptor (Fc epsilon RII/CD23) on monocytes. This finding suggests a potential role for PAF in allergic diseases.

Area of Science:

  • Immunology
  • Cell Biology
  • Allergy Research

Background:

  • The low-affinity receptor for IgE (Fc epsilon RII/CD23) plays a role in allergic responses.
  • Interleukin-4 (IL-4) is known to induce Fc epsilon RII/CD23 expression on monocytes.

Purpose of the Study:

  • To investigate the effect of platelet-activating factor (PAF) on Fc epsilon RII/CD23 expression in human monocytes.
  • To compare the effects of PAF and IL-4 on Fc epsilon RII/CD23 expression.

Main Methods:

  • Human monocytes were treated with recombinant IL-4 or PAF.
  • Fc epsilon RII/CD23 expression was assessed using flow cytometry.
  • The effects of PAF antagonists (BN 52021, BN 50730) and anti-IL-4 antiserum were evaluated.

Main Results:

  • Both IL-4 and PAF induced Fc epsilon RII/CD23 expression on human monocytes.
  • PAF-induced expression was time- and dose-dependent, with maximal effects at 1 microM PAF after 24 hours.
  • PAF-induced expression was inhibited by PAF antagonists, but not by anti-IL-4 antiserum.
  • IL-4-induced expression was abolished by anti-IL-4 antiserum and slightly reduced by PAF antagonists.

Conclusions:

  • PAF significantly regulates Fc epsilon RII/CD23 expression on human monocytes.
  • These findings suggest a novel role for PAF in the context of allergic diseases.